Golden
Cyrus Biotechnology

Cyrus Biotechnology

Biotechnology software company offering protein modelling and design capabilities.

All edits

Edits on 26 Sep 2019
Golden AI
Golden AI edited on 26 Sep 2019 11:51 am
Edits made to:
Infobox (+1 properties)
Neelam Jhaveri
Neelam Jhaveri edited on 26 Sep 2019 11:47 am
Edits made to:
Infobox (+1 properties)
Edits on 30 May 2019
Will Suter
Will Suter approved a suggestion from Golden's AI on 30 May 2019 2:15 am
Edits made to:
Article (+16/-16 characters)

Article

The company's clients include 10 of the top 20 Global Pharmaceutical firms as well as several smaller biotechnology and chemical firms. Cyrus is financed by several technology and biotechnology investors, including Trinity VenturesTrinity Ventures, Orbimed, Springrock Ventures, Alexandria Venture Investments, the W Fund, and more.

Will Suter
Will Suter approved a suggestion from Golden's AI on 30 May 2019 2:13 am
Edits made to:
Article (+4/-4 characters)

Article

This Software-as-a-Service (SaaSSaaS) product is a platform for protein structure prediction via homology modeling, protein modeling, protein stabilization, protein engineering, and protein design for biologics and small molecules. In July 2018, Cyrus announced that it would release a new immune screening and prediction tool in the platform.

Golden AI
Golden AI edited on 30 May 2019 12:56 am
Edits made to:
Infobox (+1 properties)

Infobox

Founder
Golden AI
Golden AI edited on 30 May 2019 12:56 am
Edits made to:
Infobox (+1 properties)

Infobox

Golden AI
Golden AI edited on 30 May 2019 12:56 am
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 22 Feb 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 22 Feb 2019 8:14 pm
Edits made to:
Article (+30/-30 characters)

Article

The company's clients include 10 of the top 20 Global Pharmaceutical firms as well as several smaller biotechnology and chemical firms. Cyrus is financed by several technology and biotechnology investors, including Trinity Ventures, Orbimed, Springrock Ventures, Alexandria Venture InvestmentsAlexandria Venture Investments, the W Fund, and more.

Edits on 16 Feb 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 16 Feb 2019 3:03 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 4 Feb 2019
Tianchang He
Tianchang He approved a suggestion from Golden's AI on 4 Feb 2019 11:24 pm
Edits made to:
Infobox (+4 properties)
People (+10 rows) (+20 cells) (+219 characters)

People

Name
Role
Related Golden topics

Alok Chanani

Investor



Benjamin Baker

Employee



Bryden Robertson

Employee



Craig W Philips

Investor



Gaige Pierce-Raison

Employee



Mary Larrousse

Employee



Michael Monu

Investor



Peter Novotnak

Employee



Ryan Gomoto

Employee



Steven Lewis

Employee



Infobox

Edits on 10 Jan 2019
Michael Mangus"wrong rosetta"
Michael Mangus edited on 10 Jan 2019 9:51 pm
Edits made to:
Article (+7/-7 characters)

Article

Cyrus Biotechnology is a privately held company based in Seattle, Washington. It offers protein modeling and design capabilities to the biotechnology, pharmaceutical, chemical, consumer products, and synthetic biology industries. The company's primary product is Cyrus Bench, a software package based on RosettaRosetta, a protein-modeling platform created at the University of Washington.

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 10 Jan 2019 9:48 pm
Edits made to:
Article (+7/-7 characters)

Article

Cyrus Biotechnology is a privately held company based in Seattle, Washington. It offers protein modeling and design capabilities to the biotechnology, pharmaceutical, chemical, consumer products, and synthetic biology industries. The company's primary product is Cyrus Bench, a software package based on RosettaRosetta, a protein-modeling platform created at the University of Washington.

Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 10 Jan 2019 9:48 pm
Edits made to:
Article (+7/-7 characters)

Article

Cyrus Biotechnology is a privately held company based in SeattleSeattle, Washington. It offers protein modeling and design capabilities to the biotechnology, pharmaceutical, chemical, consumer products, and synthetic biology industries. The company's primary product is Cyrus Bench, a software package based on Rosetta, a protein-modeling platform created at the University of Washington.

Edits on 9 Jan 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 9 Jan 2019 8:49 pm
Edits made to:
Article (+22/-22 characters)

Article

Cyrus Biotechnology is a privately held companyprivately held company based in Seattle, Washington. It offers protein modeling and design capabilities to the biotechnology, pharmaceutical, chemical, consumer products, and synthetic biology industries. The company's primary product is Cyrus Bench, a software package based on Rosetta, a protein-modeling platform created at the University of Washington.

Edits on 6 Jan 2019
Sameeha Sulaiman
Sameeha Sulaiman edited on 6 Jan 2019 11:22 am
Edits made to:
Article (+7/-7 characters)

Article

The company's clients include 10 of the top 20 Global Pharmaceutical firms as well as several smaller biotechnology and chemical firms. Cyrus is financed by several technology and biotechnology investors, including Trinity Ventures, OrbimedOrbimed, Springrock Ventures, Alexandria Venture Investments, the W Fund, and more.

Sameeha Sulaiman
Sameeha Sulaiman edited on 6 Jan 2019 11:17 am
Edits made to:
Infobox (+2 properties)
Description (+82 characters)
Article (+1037 characters)
People (+4 rows) (+8 cells) (+233 characters)
Related Topics (+1 topics)
Topic thumbnail

Cyrus Biotechnology

Biotechnology software company offering protein modelling and design capabilities.

Article

Cyrus Biotechnology is a privately held company based in Seattle, Washington. It offers protein modeling and design capabilities to the biotechnology, pharmaceutical, chemical, consumer products, and synthetic biology industries. The company's primary product is Cyrus Bench, a software package based on Rosetta, a protein-modeling platform created at the University of Washington.



This Software-as-a-Service (SaaS) product is a platform for protein structure prediction via homology modeling, protein modeling, protein stabilization, protein engineering, and protein design for biologics and small molecules. In July 2018, Cyrus announced that it would release a new immune screening and prediction tool in the platform.

...

The company's clients include 10 of the top 20 Global Pharmaceutical firms as well as several smaller biotechnology and chemical firms. Cyrus is financed by several technology and biotechnology investors, including Trinity Ventures, Orbimed, Springrock Ventures, Alexandria Venture Investments, the W Fund, and more.

People

Name
Role
Related Golden topics

David Baker

Scientific Co-Founder & Advisor



David Pearlman

Director of Customer Experience and Senior Fellow



Jake Litwicki

VP of Engineering



Javier Castellanos

Founder & Chief Technical Officer



Lucas Nivon

Founder & CEO



Rosario Caltabiano

Executive VP of Sales



Yifan Song

Founder & Chief Scientific Officer



Infobox

Related Topics

Edits on 1 Aug 2018
Tianchang He
Tianchang He edited on 1 Aug 2018 8:05 pm

People

Name
Role
Related Golden topics

Yifan Song

Founder



Tianchang He
Tianchang He edited on 1 Aug 2018 8:05 pm

People

Name
Role
Related Golden topics

Javier Castellanos

Founder



Edits on 13 Jul 2018
Jude Gomila
Jude Gomila edited on 13 Jul 2018 8:30 pm
Edits made to:
People (+1 rows) (+2 cells) (+18 characters)

People

Name
Role
Related Golden topics

Lucas Nivon

Founder



Edits on 21 Apr 2018
Melanie Manipula
Melanie Manipula edited on 21 Apr 2018 9:35 pm
Edits made to:
Topic thumbnail

Cyrus Biotechnology

Biotechnology software company offering protein modelling and design capabilities.